Results

Zacks Small Cap Analysis – UHAL: U-Haul Holding Firm Reviews 4Q and full-year FY2025 Outcomes. Revenues have been above expectations within the seasonally sluggish 4Q, however the backside line was impacted by rising depreciation expense in addition to by decrease resale values for retired vans. Additionally, an Annual Evaluation of FY2025. – Model Slux

by
Zacks Small Cap Analysis – UHAL: U-Haul Holding Firm Reviews 4Q and full-year FY2025 Outcomes. Revenues have been above expectations within the seasonally sluggish 4Q, however the backside line was impacted by rising depreciation expense in addition to by decrease resale values for retired vans. Additionally, an Annual Evaluation of FY2025. – Model Slux

By Steven Ralston, CFA NYSE:UHAL READ THE FULL UHAL RESEARCH REPORT EXECUTIVE SUMMARY U-Haul Holding Firm (NYSE: UHAL) reported 4Q and full-year FY2025 outcomes on Might 28th after the shut. Revenues have been above expectations within the seasonally slowest quarter, however the backside line was impacted by rising depreciation expense from the upper costs paid … Read more

Triple-I Weblog | Private Auto 2024 Underwriting Outcomes Greatest Since Pandemic – Model Slux

by
Triple-I Weblog | Private Auto 2024 Underwriting Outcomes Greatest Since Pandemic – Model Slux

By William Nibbelin, Senior Analysis Actuary, Triple-I The U.S. private auto insurance coverage business noticed a major turnaround in 2024, attaining its greatest underwriting consequence because the pandemic started, in line with Triple-I’s newest Points Transient.   In truth, with a web mixed ratio of 95.3, private auto insurance coverage has outperformed the broader property … Read more

Zacks Small Cap Analysis – TELO Produces Outcomes with Thrilling AMD Implications – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescription drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm growing a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical checks have proven proof that Telomir-1, the corporate’s main remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more

Triple-I Weblog | P&C Insurance coverage Achieves Finest Outcomes Since 2013; Wildfire Losses, Tariffs Threaten 2025 Prospects – Model Slux

by

By William Nibbelin, Senior Analysis Actuary, Triple-I The U.S. P&C insurance coverage trade’s monetary outcomes for 2024 revealed a internet mixed ratio (NCR) of 96.6, demonstrating a considerable 5.1-point enhancement in comparison with the prior 12 months and representing the sector’s most favorable underwriting efficiency since 2013, as detailed in a latest report by Triple-I … Read more

Fortunate dip from a combined bag? Abstract outcomes of the session on the analysis of EU Procurement guidelines — The best way to Crack a Nut – Model Slux

by
Fortunate dip from a combined bag? Abstract outcomes of the session on the analysis of EU Procurement guidelines — The best way to Crack a Nut – Model Slux

The European Fee has printed a Factual Abstract report on the general public session on Analysis of the Public Procurement Directives (the Abstract). Whereas we await for the Fee’s fuller evaluation of the responses to the session (which officers have publicly acknowledged to be processing with AI instruments, not less than partly) after the summer … Read more

x